<DOC>
	<DOCNO>NCT00537329</DOCNO>
	<brief_summary>The purpose study determine whether Investigational Study Drug anidulafungin safe effective treatment fungal infection , candidemia , Asian subject .</brief_summary>
	<brief_title>Anidulafungin In Treatment Of Candidemia In Asian Subjects</brief_title>
	<detailed_description />
	<mesh_term>Candidemia</mesh_term>
	<mesh_term>Anidulafungin</mesh_term>
	<mesh_term>Echinocandins</mesh_term>
	<criteria>Subjects least one positive blood test Candida pathogen blood sample take within 96 hour prior start study treatment . Subjects clinical evidence candida infection within 48 hour prior enrollment . Acute Physiology Chronic Health Enquiry ( APACHE ) score less equal 20 . Prior exposure systemic antifungal 48 hour . Subjects , time , previously receive anidulafungin . Subjects poor venous ( vein ) access would inhibit administration intravenous study drug withdraw multiple blood sample . Life expectancy &lt; 72 hour .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2010</verification_date>
</DOC>